Heather Walker

Clinical research fellow @UofGSCMH | @MMPhDHP | Big data, renal epidemiology, multimorbidity

[Multimorbidity PhD for Health Professionals @MMPhDHP]

A great day at our Annual Conference. Was brilliant to have most of our fellows from all cohorts including our newest cohort 4. Thank you to our Directors and Supervisors for attending 🌟

[UofG School of Health & Wellbeing @UofGSHW]

A common tool used by clinicians for predicting kidney failure could be underestimating the risk of failure for people with frailty.

New study led by @h_j_walker @UofGSCMH

➡️https://t.co/Sg9QFn10xA

#ChronicKidneyDisease #Frailty #UKBiobank

[KDIGO @goKDIGO]

KDIGO is pleased to share the newly published report from its Controversies Conference on Preventing CKD and Maintaining Kidney Health, now available in press in @Kidney_Int.

📄Download the report: https://t.co/gEVKYm5mG6
📘 Read the report in KI: https://t.co/RdWDEpz3Mo

Co-chaired by Dr. Alberto Ortiz and Dr. Kathy Tuttle, the conference brought together global experts and patient advocates to reframe how kidney disease is addressed, prioritizing prevention, early detection, and long-term kidney health across the lifespan.

“CKD affects over 800 million people worldwide and is one of the major unsolved challenges in global health,” said Dr. Ortiz. “We need structural changes that support proactive primary prevention in addition to earlier diagnosis and treatment—especially in low- and middle-income countries.”

“The data now show that kidney disease is not inevitable. In many cases, it can be delayed—or even prevented—if we intervene early," said Dr Tuttle. "We need to treat CKD prevention as a public health priority, like we’ve done for heart disease and diabetes. That means integrating kidney health into the entire continuum of chronic disease prevention and empowering both clinicians and patients through education and awareness.”

#kidneyhealth #publichealth #CKD

[JAGS @AGSJournal]

Multimorbidity is significantly linked to accelerated kidney function decline in older adults, with a dose–response relationship observed with the number of chronic conditions. #geriatrics https://t.co/fbVEbehGoM

[AJKD @AJKDonline]

Stopping Versus Continuing Metformin in Patients With Advanced CKD: A Nationwide Scottish Target Trial Emulation Study

https://t.co/sF4tqsKKmU #OpenAccess

@ELambourg @FuEdouard @C_H_Grant @johnrpetrie @SamiraBell76 #VisualAbstract #CKD

[National Institute for Health and Care Research @NIHRresearch]

Today we've launched a new requirement that all applicants must demonstrate how their research will address existing inequalities in health and social care as a condition of funding. Applicants will now be required to show how inclusion is being built into all stages of the research lifecycle. https://t.co/765hxygjRD

[ERA - European Renal Association @ERAkidney]

🌟 ERA is present at #KidneyWk 2024 in San Diego, California!
🤝 Stop by Booth 901 to meet the ERA Staff and grab some ERA gadgets!
📍 We can't wait to see you there! 👋

[Heather Walker @h_j_walker]

Exploring KFRE performance in frailty, use of cystatin C based eGFR and competing mortality risk

[BMC Medicine @BMCMedicine]

.@h_j_walker @GallacherKatie @BhauteshJani @C_H_Grant and colleagues assess multimorbidity and frailty within CKD cohorts to develop a prognostic model
Read the full study here: https://t.co/7Szo6UHfUB

[Heather Walker @h_j_walker]

@KaitlinMayne with her poster (no. 1047) today at ASN

Analyses from #EMPAKIDNEY - empagliflozin reduces serum uric acid with greater effects in those with higher levels of eGFR & without diabetes 🤔

Paper out now in @NDTsocial 👉🏻 https://t.co/vAQxf2epAt

#KidneyWk

[Heather Walker @h_j_walker]

Very grateful to have been able to attend the wonderful @SAfHUk Community Research Day. Such a vast range of experience and learning shared from the community, helping to shape future research 🙏🏻🧪 @MMPhDHP

[Heather Walker @h_j_walker]

Great two days at @Kidney_Research #DrivingDiscoveries hearing about some amazing research and impactful patient stories
Nice to see @C_H_Grant presenting work from his systematic review on risks of analgesics in multimorbidity 💊 @MMPhDHP

[Heather Walker @h_j_walker]

Incredibly important work from @DhanSenaratne showing adverse events in childhood are linked with developing multiple long term health conditions @MMPhDHP

https://t.co/iBEfFNhkgW

[Multimorbidity PhD for Health Professionals @MMPhDHP]

🚀 Join us for an applicant webinar with Professor Frances Mair! Learn more about our programme and application process. Please register interest here: https://t.co/TH4Z9tzoTO

[Lucy Stirland @Stirlandia]

More insightful work from @seb_walsh in @alzdemjournals
Headline: #dementia risk reduction at population level will have more effect on incidence than targeting people at highest risk

https://t.co/N55ip6yUIr

[Emily McQuarrie @mcq_emily]

Hands on #kidney #biopsy course 15th August 2024 @rcpsglasgow Great opportunity to learn / practice biopsy skills with loads of support. Spaces available! @ScottishRenal @geddescc @RenalSpRClub @rkpatel01 @UKKidney
https://t.co/NqiVeEnHps https://t.co/NqiVeEnHps

[Heather Walker @h_j_walker]

Very interesting work from @_kieransweeney developing QoL measures for use in MLTC @MMPhDHP

[Kristin Veighey @kristintp]

Great to have our @sapcacuk Kidney SIG meeting this morning at the ASM - looking forward to collaborating 😊 and more members welcome! @kidneycareuk @h_j_walker @UoS_PrimaryCare @UKKidney